School of Chinese Materia Medica, Beijing University of Chinese Medicine, Liangxiang Town, Fangshan District, Beijing, 102488, China.
School of Chinese Materia Medica, Beijing University of Chinese Medicine, Liangxiang Town, Fangshan District, Beijing, 102488, China; Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, Beijing, 102488, China.
J Ethnopharmacol. 2022 Feb 10;284:114784. doi: 10.1016/j.jep.2021.114784. Epub 2021 Oct 27.
Coptis Categorized Formula (CCF) is one of the core prescriptions in Treatise on Febrile Diseases. Its efficacy can be available not only in exogenous diseases but widely in various internal injuries and miscellaneous diseases. CCF (i.e., Huanglian Jiedu Decoction, Huanglian Ejiao Decoction, Dahuang Huanglian Xiexin Decoction, Gegen Qinlian Decoction) is different in composition, but they all play a favorable role in curative effect on type 2 diabetes mellitus (T2DM). Therefore, it is of great significance to reveal the common mechanism of CCF in treating T2DM.
Based on network pharmacology and non-targeted metabolomics research strategy, the common mechanism of the CCF treating T2DM was discussed.
Firstly, Ultra-high performance liquid chromatography-quadrupole-time of flight/mass spectrometry was used to identify the chemical constituents of the CCF. Then, the targets of these chemical components were used for network pharmacology analysis associated with therapeutic effect. Finally, the diabetic zebrafish model was constructed to further verify the common mechanism of the CCF in treating T2DM.
A total of 160 chemical compositions were identified and 16 of them were common chemical compositions of the four CCF, including berberine, baicalin, coptisine and so forth. Network pharmacology results showed that Dipeptidyl peptidase (DPP)-4, cysteinyl aspartate specific proteinase (CASP)3, nitric oxide synthase (NOS)2, NOS3, and other 37 targets were common targets of CCF, and advanced glycation end products (AGE)-receptor of advanced glycation end products (RAGE) signaling pathway in diabetic complications, mitogen-activated protein kinase (MAPK) signaling pathway and hypoxia inducible factor (HIF)-1 signaling pathway were critical pathways of four CCF in the treatment of T2DM. CCF can lessen the blood glucose of diabetic zebrafish. The contents of 25 differential metabolites in diabetic zebrafish were altered. These metabolites were mainly related to phenylalanine, tyrosine and tryptophan biosynthesis, phenylalanine metabolism, arachidonic acid metabolism, sphingolipid metabolism, and tyrosine metabolism.
Our research shows that the common mechanism of CCF in improving T2DM is as follows: berberine, baicalin, coptisine and other chemical components can directionally regulate DPP-4, CASP3, NOS2, NOS3 and other targets, which are mediated by AGE-RAGE signaling pathway in diabetic complications, MAPK signaling pathway and HIF-1 signaling pathway. The content of endogenous metabolites such as L-valine and L-sorbitose changes, and further regulates the metabolism of amino acid metabolism, lipid metabolism, purine metabolism, sphingosine metabolism and arachidonic acid metabolism, so as to play a significant role in regulating glycolipid metabolism, improving insulin resistance, inhibiting cell apoptosis, anti-oxidation and anti-inflammation, and finally ameliorating T2DM.
黄连分类方(CCF)是《伤寒论》中的核心方剂之一。它的疗效不仅在外感病中有效,而且在各种内伤病和杂病中也广泛有效。CCF(即黄连解毒汤、黄连阿胶汤、大黄黄连泻心汤、葛根芩连汤)在组成上有所不同,但它们在治疗 2 型糖尿病(T2DM)方面都有很好的疗效。因此,揭示 CCF 治疗 T2DM 的共同机制具有重要意义。
基于网络药理学和非靶向代谢组学研究策略,探讨 CCF 治疗 T2DM 的共同机制。
首先,采用超高效液相色谱-四极杆飞行时间/质谱联用技术鉴定 CCF 的化学成分。然后,利用这些化学成分的靶点进行与疗效相关的网络药理学分析。最后,构建糖尿病斑马鱼模型,进一步验证 CCF 治疗 T2DM 的共同机制。
共鉴定出 160 种化学成分,其中 16 种为四种 CCF 的共同化学成分,包括小檗碱、黄芩苷、小檗碱等。网络药理学结果表明,DPP-4、半胱氨酸天冬氨酸特异性蛋白酶(CASP)3、一氧化氮合酶(NOS)2、NOS3 等 37 个共同靶点是 CCF 的共同靶点,晚期糖基化终产物(AGE)-晚期糖基化终产物受体(RAGE)信号通路在糖尿病并发症、丝裂原激活蛋白激酶(MAPK)信号通路和缺氧诱导因子(HIF)-1 信号通路中是四种 CCF 治疗 T2DM 的关键通路。CCF 可降低糖尿病斑马鱼的血糖。糖尿病斑马鱼中 25 种差异代谢物的含量发生改变。这些代谢物主要与苯丙氨酸、酪氨酸和色氨酸生物合成、苯丙氨酸代谢、花生四烯酸代谢、鞘脂代谢和酪氨酸代谢有关。
本研究表明,CCF 改善 T2DM 的共同机制如下:小檗碱、黄芩苷、小檗碱等化学成分为能定向调节 DPP-4、CASP3、NOS2、NOS3 等靶点,这些靶点通过糖尿病并发症中的 AGE-RAGE 信号通路、MAPK 信号通路和 HIF-1 信号通路介导。内源性代谢物如 L-缬氨酸和 L-山梨醇的含量发生变化,进一步调节氨基酸代谢、脂质代谢、嘌呤代谢、鞘脂代谢和花生四烯酸代谢,从而在调节糖脂代谢、改善胰岛素抵抗、抑制细胞凋亡、抗氧化和抗炎等方面发挥显著作用,最终改善 T2DM。